Mitchell A. Hamman

2.5k total citations
22 papers, 2.0k citations indexed

About

Mitchell A. Hamman is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mitchell A. Hamman has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 11 papers in Oncology and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mitchell A. Hamman's work include Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmaceutical studies and practices (5 papers). Mitchell A. Hamman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (17 papers), Drug Transport and Resistance Mechanisms (11 papers) and Pharmaceutical studies and practices (5 papers). Mitchell A. Hamman collaborates with scholars based in United States and Singapore. Mitchell A. Hamman's co-authors include Stephen D. Hall, Steven Wrighton, Lawrence J. Lesko, Zaiqi Wang, Shiew‐Mei Huang, Gary A. Thompson, J. Christopher Gorski, Barbara J. Ring, David R. Jones and D. I. Jones and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Mitchell A. Hamman

22 papers receiving 1.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Mitchell A. Hamman	1.3k	734	388	341	256	22	2.0k
Alexander Jetter	924 0.7×	648 0.9×	351 0.9×	325 1.0×	467 1.8×	76	2.9k
J. Michael Tredger	1.1k 0.8×	403 0.5×	400 1.0×	190 0.6×	426 1.7×	109	2.9k
Qun‐Ying Yue	835 0.6×	328 0.4×	187 0.5×	262 0.8×	325 1.3×	35	1.6k
J. Andrew Williams	1.6k 1.2×	1.1k 1.5×	440 1.1×	224 0.7×	679 2.7×	31	2.6k
Ruth Hyland	1.5k 1.2×	734 1.0×	289 0.7×	300 0.9×	639 2.5×	31	2.5k
Myung G. Lee	1.2k 0.9×	880 1.2×	455 1.2×	431 1.3×	511 2.0×	148	2.2k
Zhi‐Rong Tan	1.2k 0.9×	704 1.0×	372 1.0×	412 1.2×	774 3.0×	103	2.8k
Einosuke Tanaka	1.0k 0.8×	570 0.8×	316 0.8×	319 0.9×	309 1.2×	139	2.3k
Lisa L. von Moltke	1.2k 0.9×	596 0.8×	296 0.8×	388 1.1×	265 1.0×	22	2.0k
Kenneth S. Lown	1.7k 1.3×	1.5k 2.1×	878 2.3×	331 1.0×	369 1.4×	23	3.0k

Countries citing papers authored by Mitchell A. Hamman

Since Specialization

Citations

This map shows the geographic impact of Mitchell A. Hamman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell A. Hamman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell A. Hamman more than expected).

Fields of papers citing papers by Mitchell A. Hamman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell A. Hamman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell A. Hamman. The network helps show where Mitchell A. Hamman may publish in the future.

Co-authorship network of co-authors of Mitchell A. Hamman

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell A. Hamman. A scholar is included among the top collaborators of Mitchell A. Hamman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell A. Hamman. Mitchell A. Hamman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quinney, Sara K., Raj Vuppalanchi, Mitchell A. Hamman, et al.. (2012). Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin. European Journal of Clinical Pharmacology. 69(3). 439–448. 24 indexed citations

Misra, Vijay Laxmi, Raj Vuppalanchi, David Jones, et al.. (2010). The effects of midodrine on the natriuretic response to furosemide in cirrhotics with ascites. Alimentary Pharmacology & Therapeutics. 32(8). 1044–1050. 12 indexed citations

Quinney, Sara K., Raymond E. Galinsky, Yong Chen, et al.. (2008). Hydroxyitraconazole, Formed During Intestinal First-Pass Metabolism of Itraconazole, Controls the Time Course of Hepatic CYP3A Inhibition and the Bioavailability of Itraconazole in Rats. Drug Metabolism and Disposition. 36(6). 1097–1101. 25 indexed citations

Jin, Yan, et al.. (2007). Cytochrome P450 3A5 Genotype is Associated with Verapamil Response in Healthy Subjects. Clinical Pharmacology & Therapeutics. 82(5). 579–585. 33 indexed citations

Li, Lang, et al.. (2005). DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE. Drug Metabolism and Disposition. 33(7). 1052–1055. 32 indexed citations

Horlander, John C., Naga Chalasani, Mitchell A. Hamman, et al.. (2005). Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein. British Journal of Clinical Pharmacology. 59(4). 440–446. 26 indexed citations

Chalasani, Naga, Todd C. Skaar, Dhanashri Kolwankar, et al.. (2005). Inhibition of Human Intestinal Wall Metabolism by Macrolide Antibiotics: Effect of Clarithromycin on Cytochrome P450 3A4/5 Activity and Expression*. Clinical Pharmacology & Therapeutics. 77(3). 178–188. 46 indexed citations

Lucksiri, Aroonrut, Raj Vuppalanchi, Mitchell A. Hamman, et al.. (2005). Dose dependent inhibition of midazolam elimination by ketoconazole: Effect of CYP3A5 genotype. Clinical Pharmacology & Therapeutics. 77(2). P35–P35. 4 indexed citations

Hamman, Mitchell A., et al.. (2003). The effect of verapamil administration on the pharmacokinetics of fexofenadine. Clinical Pharmacology & Therapeutics. 73(2). 1 indexed citations

10.

Williams, J. Andrew, Barbara J. Ring, David R. Jones, et al.. (2002). Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug Metabolism and Disposition. 30(8). 883–891. 383 indexed citations

11.

Wang, Zaiqi, Mitchell A. Hamman, Shiew‐Mei Huang, Lawrence J. Lesko, & Stephen D. Hall. (2002). Effect of St John's wort on the pharmacokinetics of fexofenadine. Clinical Pharmacology & Therapeutics. 71(6). 414–420. 154 indexed citations

12.

Wang, Zaiqi, et al.. (2001). The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.. PubMed. 70(4). 317–26. 96 indexed citations

13.

Wang, Zaiqi, J. Christopher Gorski, Mitchell A. Hamman, et al.. (2001). The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Clinical Pharmacology & Therapeutics. 70(4). 317–326. 107 indexed citations

14.

Hamman, Mitchell A., et al.. (2000). Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases. Biochemical Pharmacology. 60(1). 7–17. 71 indexed citations

15.

Gorski, J. Christopher, Drew R. Jones, Mitchell A. Hamman, Steven Wrighton, & Stephen D. Hall. (1999). Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily. Xenobiotica. 29(9). 931–944. 54 indexed citations

16.

Gorski, Jack, et al.. (1998). The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin*. Clinical Pharmacology & Therapeutics. 64(2). 133–143. 336 indexed citations

17.

Hamman, Mitchell A., Gary A. Thompson, & Stephen D. Hall. (1997). Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochemical Pharmacology. 54(1). 33–41. 189 indexed citations

18.

Ring, Barbara J., John T. Catlow, Thomas J. Lindsay, et al.. (1996). Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 658–666. 170 indexed citations

19.

Jones, David R., John Gorski, Mitchell A. Hamman, & Stephen D. Hall. (1996). Quantification of dextromethorphan and metabolites: a dual phenotypic marker for cytochrome P450 3A4/5 and 2D6 activity. Journal of Chromatography B Biomedical Sciences and Applications. 678(1). 105–111. 51 indexed citations

20.

Hall, Stephen D., Mitchell A. Hamman, Allan E. Rettie, et al.. (1994). Relationships between the levels of cytochrome P4502C9 and its prototypic catalytic activities in human liver microsomes.. Drug Metabolism and Disposition. 22(6). 975–978. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact